Shop
Pick what you're after and answer five questions. A doctor licensed in your state decides — and your card isn't touched until they do.
GLP-1 receptor agonist
or $649 one-time starter
The branded, FDA-approved product — not a compounded copy. A once-weekly injection with the deepest trial record in this category.
Dual GIP / GLP-1 agonist
or $749 one-time starter
Two incretin receptors instead of one. The largest average weight reduction published for a drug in this class, and a correspondingly slower ladder.
Growth hormone secretagogue
or $249 one-time starter
Prompts your own pituitary rather than replacing the hormone. Taken nightly, timed to the pulse your body already produces in deep sleep.
GHRH analogue · FDA-approved
or $549 one-time starter
One of the very few genuinely FDA-approved peptides — for visceral fat, on a specific indication we spell out rather than blur.
Choosing
Answer the five questions first and see where a physician would usually start — your answers carry straight into the request.
Semaglutide is where most people start — one receptor, a shorter ladder, fewer first-month surprises. Tirzepatide acts on two receptors and produced more weight loss in trials, at the cost of a longer, slower titration. A physician will steer you if your intake points one way.
Because we do not dispense it. Nearly all the published work is in animals and its compounding status is unresolved. We keep a page explaining that in full, with citations, rather than quietly leaving it off the list.
It prompts your own pituitary rather than replacing a hormone, so it is dosed nightly and judged on week-12 bloodwork rather than how you feel in week two.
